Share on StockTwits

Insmed (NASDAQ:INSM) Director Melvin Md Sharoky acquired 88,889 shares of Insmed stock in a transaction dated Wednesday, August 13th. The shares were purchased at an average price of $11.25 per share, with a total value of $1,000,001.25. Following the completion of the purchase, the director now directly owns 260,469 shares of the company’s stock, valued at approximately $2,930,276. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Insmed (NASDAQ:INSM) opened at 13.18 on Monday. Insmed has a one year low of $11.15 and a one year high of $22.29. The stock’s 50-day moving average is $16.70 and its 200-day moving average is $16.42. The company’s market cap is $517.7 million.

Insmed (NASDAQ:INSM) last announced its earnings results on Wednesday, August 6th. The company reported ($0.59) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.46) by $0.13. Analysts expect that Insmed will post $-1.88 EPS for the current fiscal year.

Insmed Incorporated is a biopharmaceutical company focused on patients suffering with lung diseases through the development and commercialization of targeted inhalation therapies.

Receive News & Ratings for Insmed Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insmed Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.